帕金森病的整体健康处方:基于证据的观点和未满足的需求
Indu Subramanian1,2, Lucia Ricciardi3, Anette Schrag4
1Veterans Affairs Greater Los Angeles, Los Angeles, California, USA.
Movement disorders clinical practice
|October 14, 2025
概括
在神经学,特别是帕金森病 (PD) 中,健康整合至关重要. 本综述综合了证据,确定了知识差距,并提出了全面的PD护理框架,强调主动的大脑健康策略.
科学领域:
- 神经学 神经学
- 公共卫生 公共卫生
- 养生研究 保健研究
背景情况:
- 由于定义不清楚和商业化,医学的健康概念面临误解.
- 养生是建立在慢性疾病的管理中,但在神经学中未得到充分利用.
- 对大脑健康和生活方式干预的日益重视与健康原则保持一致.
研究的目的:
- 审查帕金森病 (PD) 中健康的证据基础.
- 识别目前对PD患者健康状况的理解中的知识差距.
- 提出一个框架,将健康整合到整体的PD护理.
主要方法:
- 由一个多学科工作组进行批判性审查.
- 由国际帕金森和运动障碍学会委托制作.
- 综合当前关于PD健康的证据.
主要成果:
- 关于PD健康的证据基础需要进一步发展.
- 在了解健康在PD中的作用方面存在重大差距.
- 目前缺乏在PD护理中对健康的结构化方法.
结论:
- 提出了一个框架,将健康整合到整体的PD护理中.
- 主动性大脑健康和生活方式选择是神经学结果的关键.
- 需要进一步的研究,以充分利用健康在PD管理.
相关概念视频
Parkinson's Disease: Treatment
983
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
983
Parkinson's Disease: Overview
1.8K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.8K
Drug Therapy
242
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
242
Alzheimer's Disease: Treatment
822
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
822
Documentation in Long-Term and Home Healthcare Setting
1.4K
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
1.4K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K


